Background/Aims: Although increased oxidative stress plays a role in heart failure (HF)-induced skeletal myopathy, signaling pathways involved in muscle changes and the role of antioxidant agents have been poorly addressed. We evaluated the effects of N-acetylcysteine (NAC) on intracellular signaling pathways potentially modulated by oxidative stress in soleus muscle from HF rats. Methods and Results: Four months after surgery, rats were assigned to Sham, myocardial infarction (MI)-C (without treatment), and MI-NAC (treated with N-acetylcysteine) groups. Two months later, echocardiogram showed left ventricular dysfunction in MI-C; NAC attenuated diastolic dysfunction. Oxidative stress was evaluated in serum and soleus muscle; malondialdehyde was higher in MI-C than Sham and did not differ between MI-C and MI-NAC. Oxidized glutathione concentration in soleus muscle was similar in Sham and MI-C, and lower in MI-NAC than MI-C (Sham 0.168 ± 0.056; MI-C 0.223 ± 0.073; MI-NAC 0.136 ± 0.023 nmol/mg tissue; p = 0.014). Western blot showed increased p-JNK and decreased p38, ERK1/2, and p-ERK1/2 in infarcted rats. NAC restored ERK1/2. NF-κB p65 subunit was reduced; p-Ser276 in p65 and IκB was increased; and p-Ser536 unchanged in MI-C compared to Sham. NAC did not modify NF-κB p65 subunit, but decreased p-Ser276 and p-Ser536. Conclusion: N-acetylcysteine modulates MAPK and NF-κB signaling pathways in soleus muscle of HF rats.
Modulation of MAPK and NF-κB Signaling
Myocardial infarction (MI) was induced by ligating the anterior descending coronary artery [28] . Four months later, rats were assigned to three groups: Sham, MI-C (MI without treatment), and MI-NAC (MI treated with N-acetylcysteine, 120 mg/kg/day). Six months after surgery, rats were euthanized. At euthanasia, two observers determined whether the clinical and pathologic HF features were present or absent. Tachypnea/ labored respiration was the clinical finding. Pathologic findings included pleuropericardial effusion, left atrial thrombi, pulmonary congestion (lung weight-to-body weight ratio >2 standard deviation above sham group mean), and right ventricular hypertrophy (right ventricle weight-to-body weight ratio >0.8 mg/g) [29] [30] [31] .
Echocardiographic evaluation
Echocardiogram was performed before and after NAC treatment (Vivid S6, General Electric Medical Systems, Tirat Carmel, Israel) using a 5 to 11.5 MHz multifrequency probe, according to a previously described method [32] [33] [34] .
Rats were anesthetized by intramuscular injection of a mixture of ketamine (50 mg/kg) and xylazine (0.5 mg/kg). A two-dimensional parasternal short-axis view of the left ventricle (LV) was obtained at the level of the papillary muscles. M-mode tracings were obtained from short-axis views of the LV at or just below the tip of the mitral-valve leaflets, and at the level of the aortic valve and left atrium. M-mode images of the LV were printed on a black-and-white thermal printer (Sony UP-890MD). All cardiac structures were manually measured by the same observer (K.O.) according to the leading-edge method of the American Society of Echocardiography [35] . The measurements obtained were the mean of at least five cardiac cycles on the M-mode tracings. The following structural variables were measured: left atrium (LA) diameter, LV diastolic and systolic dimensions (LVDD and LVSD, respectively), LV diastolic posterior wall thickness (PWT), and aortic diameter (AO). Left ventricular function was assessed by the following parameters: endocardial fractional shortening (FS), fractional area change (FAC), posterior wall shortening velocity (PWSV), earlyto-late diastolic mitral inflow velocities (E/A) ratio, E-wave deceleration time (EDT), and isovolumetric relaxation time (IVRT).
Infarct size
Left ventricle (LV) samples were fixed in a 10% buffered formalin solution for 48 h and stained with haematoxylin and eosin. Infarction size was calculated by dividing the sum of endocardial and epicardial infarcted ventricular lengths by the sum of total (infarcted and viable myocardial) endocardial and epicardial ventricular circumferences. The measurements were acquired from midventricular slices (5-6 mm from the apex) and analysed in a microscope (Leica DM LS; Nussloch, Germany) attached to a computerized imaging analysis system (Media Cybernetics, Silver Spring, MD, USA) [28] . Rats with small MI size (< 30%) were excluded from this study.
Skeletal muscle morphology
Serial transverse sections of the soleus muscles mid belly were cut at 10 µm thicknesses in a cryostat cooled to -20°C. The general morphology and cross-sectional fiber areas were evaluated in sections stained with haematoxylin and eosin. At least 200 cross-sectional fiber areas were measured from each soleus muscle. The measurements were performed using a compound microscope (Leica DM LS; Nussloch, Germany) attached to a computerized imaging analysis system (Media Cybernetics, Silver Spring, MD, USA) [36] .
Myosin heavy chain (MyHC) isoforms
MyHC isoform analysis was performed in duplicate by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) [36] . Frozen samples of soleus muscle were homogenized in 0.8 mL of solution containing 50 mM phosphate potassium buffer (pH 7.0), 0.3 M sucrose, 0.5 mM dithiotreitol (DTT), 1 mM ethylenediaminetetracetic acid (EDTA), 0.3 mM phenylmetylsulphonyl fluoride, 10 mM sodium fluoride, and protease inhibitor cocktail (Sigma, St. Louis, MO, USA). Homogenates were centrifuged at 12,000 g at 4°C for 20 min to remove insoluble tissue. After quantification of total protein in the supernatant, samples were diluted to a final concentration of 1 µg of protein/µL in a solution containing 65 % (vol/vol) glycerol, 2.5% (vol/vol) 2-mercaptoethanol, 1.15% (wt/vol) SDS, and 0.45% (wt/vol) Tris-HCl (pH 6.8). Twelve μL of the diluted extracts were loaded onto a 7-10% SDS-PAGE separating gel with a 4 % stacking gel, run overnight at 70 V, and stained with Coomassie blue. Two MyHC isoforms, MyHC I and MyHC IIa, were identified according to molecular mass and quantified by densitometry. Their relative amounts were expressed as the percentage of total myosin heavy chain amount.
Metabolic enzymes activity
Soleus muscle samples (~200 mg) were homogenized in 5 mL of a cold 0.1 M phosphate buffer, pH 7.4. Tissue was homogenized and centrifuged (10,000 × g) for 15 min; the supernatant was assayed for total protein, β-hydroxyacyl coenzyme-A dehydrogenase (OHADH, E.C.1.1.1.35.), and citrate synthase (CS, E.C.4.1.3.7.) activities by spectrophotometry, as previously described [37] .
Malondialdehyde serum concentration
Lipid peroxidation was assessed by measuring malondialdehyde (MDA) by high performance liquid chromatography (HPLC), as reported previously [38] . MDA was quantified by comparison of integrated peak areas between samples and standard solution under identical chromatographic conditions.
3-Nitrotyrosine serum concentration
Nitrotyrosine concentration was measured by enzyme-linked immunosorbent assay (ELISA) using OxiSelect TM Nitrotyrosine ELISA Kit (STA-305, Cell Biolabs, San Diego, CA, USA).
Circulating TNF-α TNF-α serum concentration was measured by ELISA using a rat TNF-α kit (#KCR3011, Invitrogen, Camarillo, CA, USA).
Real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR)
Soleus muscle total RNA was extracted with TRIzol reagent. cDNA was submitted to real time PCR using a customized assay containing sense and antisense primers and a Taqman probe (Applied Biosystems, Foster City, CA, USA) specific to each gene: myogenin (Taqman assay Rn00567418_m1), MyoD (Rn00598571_m1), and MRF4 (Rn00565920_m1) [39, 40] . Expression data were normalized to reference gene expressions: cyclophilin (Rn00690933_m1), and GAPDH (Rn01775763_g1).
Western blot
Protein levels were analyzed using specific antibodies (Santa Cruz Biotechnology Inc., CA, USA): MyoD (sc-760), myogenin (sc-576), MRF4 (sc-301), p-JNK (sc-6254), total JNK1/2 (sc-137019), p-ERK1/2 (sc-16982), total ERK 1 (sc-93), p-p38-MAPK (sc-17852), total p38-MAPK (sc-7972), p-IκB-α (sc-101713), total IκB-α (sc-1643), Ser 276 p-p65 NF-κB (sc-101749), Ser 536 p-p65 NF-κB (sc-33020), total p65 NF-κB (sc-7151), p-Src (sc-101802), total Src (sc-5266), p-MSK1 (sc-130205), and total MSK1 (sc-25417). Protein levels were normalized to those of GAPDH (6C5-sc-32233) [41, 42] .
Briefly, soleus muscle tendons were discarded and only the muscle belly was used for protein analysis. Muscle protein was extracted using RIPA buffer (containing proteases and phosphatases inhibitors) and the protein content of supernatant was quantified by the Bradford's method. Samples were separated on a polyacrylamide gel and then transferred to a nitrocellulose membrane. After blockage, membrane was incubated with the primary antibodies. Membrane was washed with TBS and Tween 20 and incubated with secondary peroxidase-conjugated antibodies. Super Signal ® West Pico Chemiluminescent Substrate (Pierce Protein Research Products, Rockford, USA) was used to detect bound antibodies.
Glutathione concentration and redox status in soleus muscle
Soleus muscle fragments (30 -40 mg) were homogenized in 100 mM phosphate buffer (pH 7.0; 250 µL/10 mg tissue), and centrifuged at 12000 g for 10 min at 4°C. A sample of the supernatant (200 µL) was transferred to another tube and 5% sulphosalicylic acid (200 µL) was added to precipitate proteins. Then, Glutathione Fluorescent Detection Kit (Arbor Assays) was added to quantify glutathione total concentration and redox status. The kit utilizes a non-fluorescent molecule, ThioStar ® , which covalently binds to the free thiol group of glutathione and yields a highly fluorescent product. After mixing the samples with ThioStar ® and incubating for 15 min at room temperature, the fluorescent product was read (excitation 390 nm, emission 510 nm) in a spectrofluorometer (Spectramax 340, Molecular Devices) and reduced (or free) glutathione (GSH) concentration was measured. Subsequently, a reaction mixture was added to convert all the oxidized glutathione (GSSG) into free GSH, which then reacted with the excess of ThioStar ® to yield the signal related to total glutathione content. A standard curve was used to calculate total and reduced glutathione concentrations. Oxidized glutathione concentration was obtained by the following calculation: GSSG = (Total GSH -reduced GSH)/2. Results were normalized to the muscle fragment weight.
Statistical analysis
Data are expressed as mean ± standard deviation. Comparisons between groups were performed by one-way ANOVA and Bonferroni post hoc test (interest comparisons: Sham versus MI-C and MI-C versus MI-NAC). The Student's t-test was used to compare MI size. Frequency of heart failure features was assessed by the Goodman test. Significance level was set at 5%.
Results

Experimental groups and anatomical variables
Sham group rats (n = 24) did not present any HF features. The frequency of HF features did not differ between MI-NAC and MI-C groups (Table 1) . Anatomical data are presented in Table 2 . Soleus muscle weight (Sham 0.24 ± 0.03; MI-C 0.24 ± 0.04; MI-NAC 0.23 ± 0.03 g) and soleus weight-to-body weight ratio (Sham 0.48 ± 0.07; MI-C 0.49 ± 0.05; MI-NAC 0.47 ± 0.07 mg/kg) did not differ between groups. The lack of skeletal muscle atrophy suggests that we have evaluated our rats before the heart failure-induced catabolic state was completely activated. MI size did not differ between MI-C (47.6 ± 5.9%) and MI-NAC (47.7 ± 8.3%) groups. 
Echocardiograph evaluation
Before NAC administration, all echocardiographic variables were similar between MI-C and MI-NAC groups (data not shown). Cardiac structural and LV function variables evaluated at the end of the experiment are shown in Tables 3 and 4 , respectively.
Skeletal myopathy characterization
Fiber cross sectional areas did not differ between groups (Sham 3,408 ± 381; MI-C 3,775 ± 490; MI-NAC 3,784 ± 513 µm 2 ; p > 0.05). Representative histological sections of haematoxylin and eosin-stained soleus muscle are presented in Fig. 1 .
β-hydroxyacyl coenzyme-A dehydrogenase activity was lower in MI-C than Sham and similar in MI-C and MI-NAC (Sham 73.6 ± 9.8; MI-C 61.0 ± 7.0; MI-NAC 59.5 ± 5.1 nmol/mg protein; p = 0.002). Citrate synthase activity tended (p = 0.081) to be lower in MI-C than Sham, and was lower (p = 0.003) in MI-NAC than MI-C (Sham 168 ± 23; MI-C 148 ± 16; MI-NAC 115 ± 15 nmol/mg protein; p < 0.001).
The percentage of myosin heavy chain IIa isoform was lower in MI-C than Sham, and higher in MI-NAC than MI-C (Sham 22.2 ± 4.46; MI-C 15.9 ± 3.56; MI-NAC 20.6 ± 3.26 %; p = 0.009). Myosin heavy chain representative bands are shown in Fig. 2 .
Systemic oxidative stress MDA serum concentration was higher in MI-C compared to Sham and did not differ between MI-C and MI-NAC (Sham 0.98 ± 0.07; MI-C 1.22 ± 0.10; MI-NAC 1.37 ± 0.16 µmol/ mL; p < 0.001), showing that both infarcted groups presented increased systemic lipid peroxidation. However, as serum concentration of 3-nitrotyrosine was similar in Sham and 
MI-C, and lower in MI-NAC than MI-C (Sham 126 ± 50; MI-C 176 ± 50; MI-NAC 98 ± 48 nM; p = 0.032), we can conclude that systemic oxidative stress was attenuated by NAC. Fig. 3 . Phosphorylated ERK (p-ERK) was lower in MI-C than in Sham (Sham 1.00 ± 0.32; MI-C 0.57 ± 0.11; MI-NAC 0.82 ± 0.35 arbitrary units; p = 0.021). Total ERK was lower in MI-C than Sham and higher in MI-NAC than in MI-C (Sham We next showed that N-acetylcysteine reduced phosphorylation of NF-κB (Fig. 4) . Serine 276-phosphorylated NF-κB (Ser 276 NF-κB) was higher in MI-C than in Sham and lower in MI-NAC than in MI-C (Sham 1.00 ± 0.45; MI-C 1.40 ± 0.25; MI-NAC 0.95 ± 0.25 arbitrary units; p = 0.022). Serine 536-phosphorylated NF-κB (Ser 536 NF-κB) did not differ between MI-C and Sham and was lower in MI-NAC than in MI-C (Sham 1.00 ± 0.16; MI-C 0.85 ± 0.11; MI-NAC 0.46 ± 0.17 arbitrary units; p < 0.001). Total NF-κB was lower in MI-C than in Sham (Sham 1.00 ± 0.25; MI-C 0.73 ± 0.10; MI-NAC 0.68 ± 0.18 arbitrary units; p = 0.005). These in vivo results are in accordance with data from cell culture showing that under TNF-α stimulation, antioxidant intervention did not prevent JNK activation, but reduced p65-Ser276 residue phosphorylation and expression of TNF-α-inducible NF-κB-dependent genes [43] .
Glutathione concentration and redox status in soleus muscle
Protein levels MAPK proteins expression is shown in
MAPK and NF-κB signaling pathways-related proteins expression is shown in Fig. 5 . Phosphorylated IκB (p-IκB) was higher in MI-C than in Sham and similar between MI-C and 
Discussion
This study evaluated the influence of the antioxidant N-acetylcysteine on systemic oxidative stress and the intracellular signaling pathways MAPK and NF-κB in slow-twitch skeletal muscle of heart failure rats.
The MI rat has been a commonly used experimental model for inducing LV dysfunction and heart failure [28] . Ensuing heart failure develops slowly, as usually occurs in clinical settings. However, only rats with moderate to large MI develop HF [28] . In this study, groups MI-C and MI-NAC presented similar infarct sizes, approximately 48%, which is considered large. Heart failure diagnosis was based on observation of clinical and pathologic features [28, 44] . The higher right ventricle and lung weights in MI-C than Sham group confirmed heart failure diagnosis. N-acetylcysteine did not modify the frequency of heart failure features or right ventricle and lung weights.
Before N-acetylcysteine treatment, echocardiogram showed that MI-C and MI-NAC groups had a similar degree of cardiac injury (data not shown). At the end of experimental period, echocardiographic analysis showed that MI-C animals presented dilated left cardiac chambers with systolic and diastolic LV dysfunction compared to the Sham rats. Diastolic dysfunction in the MI-C group showed a restrictive pattern with an increased E/A ratio, which characterizes severe dysfunction [28] . Late treatment with NAC did not attenuate structural cardiac changes or systolic ventricular dysfunction. However, diastolic dysfunction was slightly improved as the E/A ratio was lower in MI-NAC than MI-C. Other authors have initiated NAC administration 24 hours [45] or two months [27] after inducing MI and observed attenuation of cardiac remodeling and improvement of systolic function. As in this study NAC was started four months after MI, it is probable that an advanced degree of cardiac injury was already established preventing a reverse remodeling process.
In our study, HF-induced skeletal myopathy was characterized by changes in metabolic enzymes activity and myosin heavy chain distribution in soleus muscle. Rats with heart failure presented decreased oxidative metabolism and more pronounced slow-twitch muscle fiber phenotype in soleus muscle. Furthermore, increased systemic oxidative stress was demonstrated by the higher malondialdehyde serum concentration in MI-C group compared to the Sham. In a previous work, we showed that increased oxidative stress also occurs in the soleus muscle of infarcted rats [14] . Oxidative stress has been related to changes in myofibrils and intrinsic myosin dysfunction during heart failure [46] [47] [48] . NAC administration did not change malondialdehyde levels, but reduced 3-nitrotyrosine concentration and oxidized glutathione compared to the MI-C group.
In this study, we showed for the first time that N-acetylcysteine administration modulates the MAPK and NF-κB intracellular signalling pathways in response to reactive oxygen species stimulus in slow-twitch skeletal muscle during HF.
Studies have shown that NF-κB and MAPK are critical pathways for muscle cell management of oxidative stress. In vitro, it is well stablished that oxidative stress activates both, MAPK and NF-κB pathways in C2 skeletal myoblasts, which resemble what happens in adult muscle satellite cells [49] . However, adult skeletal muscle response to increased ROS concentration may diverge from skeletal myoblast response, mainly due to differences in experimental model and interaction with other stimuli.
ERKs main function is related to anabolic processes such as cellular division, growth, and differentiation, while JNKs and p38-MAPK functions are associated to cellular responses to stress [15] . In C2 skeletal myoblasts, H 2 O 2 induced strong ERK activation in a time-and dose-dependent profile [49] . In our study, however, we observed ERK1/2 activation was reduced in skeletal muscle and probable not related to ROS levels. On the other hand, ERK1/2 signaling has been associated with IGF-1-mediated hypertrophic effects in skeletal muscle [50] . Considering that IGF-1 and growth hormone are lower during HF [6, 51] , inhibited ERK signaling was expected, as observed in this study. Simultaneous ERK and p38MAPK inhibition, associated with JNK activation in the infarcted rats may also have occurred due to dual specificity MAPK phosphatases (MKPs) activity, by still unclear mechanisms [52] . Shi et al. [53] demonstrated that ERK inhibition can be modulated in muscle cells by MAPK phosphatase MKP1. Another study demonstrated that ERK1/2 inhibition decreases fast fiber-specific gene and protein expression and induces the slow muscle fiber phenotype program in vitro and in vivo [54] . The role of p38 MAPK in myogenesis is related to both transcription and activation of muscle-specific transcription factors [19, 55] . In our model, although p38 MAPK level was reduced in infarcted rats soleus muscle, MRF gene and protein expression was unchanged. NAC treatment only increased MRF4 gene expression, which was not combined with protein expression changes. The preserved MRF protein expression is coherent with both preserved mass and cross sectional fiber area in soleus muscle.
Previous studies have shown that Src is involved in MAPK activation, specifically JNK and ERK, stimulated by ROS [18] . Src activation also stimulates phosphorylation of JNK and Ser276 residue in NF-κB p65 subunit, in an ERK/MSK1 activation dependent way, and phosphorylation of Ser536 residue in NF-κB p65 subunit, independently of ERK activation [49] . In our study, Src and Ser536 residue phosphorylation levels in NF-κB p65 subunit were preserved in MI-C group and reduced in MI-NAC. However, JNK and p65-Ser276 residue phosphorylation behaviour was comparable to a chronic TNF-α activation response pattern. Jamaluddin et al. [43] showed that in cultured monocytes, acute TNF-α stimulation activates the three MAPK and MSK1. However, during chronic TNF-α stimulation, only JNK activation is sustained. Moreover, JNK activation was necessary for TNF-α-induced ROS generation, and ROS acted as second messengers for JNK and NF-κB interaction [43] . Also, under TNF-α stimulation, antioxidant intervention did not attenuate JNK activation, but reduced p65-Ser276 residue phosphorylation which is mediated by cAMP-dependent protein kinase A and not related to MSK1 [43] . In our study, NF-κB phosphorylation in different serine residues is at least in part related to oxidative stress as discussed above. However, we observed that increased IκB phosphorylation in infarcted rats was not modulated by NAC treatment, indicating augmented NF-κB activation, which is associated to increased circulating TNF-α [43] .
Conclusion
We provide the first evidence that the antioxidant N-acetylcysteine can modulate MAPK and NF-κB signaling pathways in soleus muscle of rats with heart failure. Martinez 
